Retinoic acid maintains differentiated cell morphology and functions in long-term cultured porcine hepatocytes: Obtaining functional cells for prolonged treatments with bioartificial liver

International Journal of Artificial Organs

Volumn 26, Issue 6, 2003, Pages 498-506

  Bertagnolo, V ^a   Puviani, A C ^a   Brogli, M ^a   Carini, C ^a   Brugnoli, F ^a   Colamussi, M L ^a   Bellini, G ^b   Morsiani, Eugenio ^a   Capitani, S ^a,c  

^a UNIVERSITY OF FERRARA   (Italy)

^b Rand Srl   (Italy)

^c International Cancer Center   (Italy)

Author keywords

All trans retinoic acid (ATRA),; Bioartificial liver (BAL); Phosphoinositide dependent phospholipase C (PLC); Porcine hepatocytes; Protein kinase C (PKC)

Indexed keywords

AMINO ACIDS; BODY FLUIDS; CELLS; CYTOLOGY; METABOLISM; MORPHOLOGY; PATIENT TREATMENT;

ALL TRANS-RETINOIC ACID ,; ALL-TRANS-RETINOIC ACID; BIOARTIFICIAL LIVER; HEPATOCYTES; PHOSPHOINOSITIDE-DEPENDENT PHOSPHOLIPASE C; PHOSPHOINOSITIDES; PHOSPHOLIPASE C; PORCINE HEPATOCYTE; PROTEIN KINASE C; PROTEIN KINASES C;

ARTIFICIAL ORGANS;

LIDOCAINE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE BETA3; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE GAMMA1; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA2; RETINOIC ACID; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ARTIFICIAL LIVER; CELL ACTIVITY; CELL CYCLE; CELL FUNCTION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; LIVER CELL CULTURE; LIVER PARENCHYMA; LONG TERM CARE; MORPHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SERUM; SWINE;

EID: 0043167822     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600608     Document Type: Article

References (33)

1. Puviani AC, Ottolengi C, Tassinari B, Pazzi P, Morsiani E. An update on high-yield hepatocyte isolation methods and on the potential clinical use of isolated liver cells. Comp Biochem Physiol A Mol Integr Physiol 1998; 121: 99-109.
2. Enat R, Jefferson DM, Ruiz-Opazo N, Gatmaitan Z, Leinwand LA, Reid LM. Hepatocyte proliferation in vitro: Its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci USA 1984; 81: 1411-5.
3. Guery C, Stepniewski JP, Vannier B, Fournex R, Lorenzon G. Long-term culture of rat hepatocytes on porous membranes in hormonally defined serum-free medium. Toxic In Vitro 1993; 7: 453-9.
4. Bissel DM, Areson DM, Maher JJ, Roll FJ. Support of cultured hepatocytes by a laminin-rich gel. J Clin Invest 1987; 79: 801-12.
5. Wu FJ, Friend JR, Remmel RP, Cerra FB, Hu WS. Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant 1999; 8: 233-46.
6. Sachs DA. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994; 43: 185-91.
7. Desille M, Corcos L, L'Helgoulac'h A, Fremond B, Campion J-P, Guillouzo A, Clement B. Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation 1999; 68: 1437-43.
8. Watanabe FD, Mullon CJP, Hewitt WR, Salomon B, Rozga J, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical trial. Ann Surg 1997; 225: 484-94.
9. Gerlach JC, Enche J, Hole O, Muller C, Ryan CJ, Neuhaus P. Bioreactor for a longer scale hepatocyte in vitro perfusion. Transplantation 1994; 58: 984-8.
10. Flendrig LM, Calise F, Di Florio E, Mancini A, Cervello A, Santaniello W, Mezza A, Sicoli F, Bellezza G, Bracco A, Cozzolino S, Scala D, Mazzone M, Fattore M, Gonzales S, Chamuleau RAFM. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 1999; 22: 701-8.
11. Morsiani E, Pazzi P, Puviani AC, Brogli M, Velieri L, Gorini P, Scoletta P, Marangoni E, Ragazzi R, Azzena G, Frazzoli E, Di Luca D, Cassai E, Lombardi G, Cavallai A, Faenza S, Passetto A, Girardis M, Jovine E, Pinna AD. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs 2002; 25: 192-202.
12. Morsiani E, Brogli M, Galavotti G, Pazzi P, Puviani AC, Azzena GF. Biologic liver support: Optimal cell source and mass. Int J Artif Organs 2002; 25: 985-93.
13. Rogers MB. Retinoids. A window into vertebrate development. J Fla Med Assoc 1994; 81: 553-6.
14. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936-40.
15. Castaigne S, Chomienne C, Daniel MT. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1980; 76: 1704-9.
16. Falasca L, Favale A, Gualandi G, Maietta G, Conti Devirgiliis L. Retinoic acid treatment induces apoptosis or expression of a more differentiated phenotype on different fractions of cultured fetal rat hepatocytes. Hepatology 1998; 28: 727-37.
17. Falasca L, Favale, A, Serafino A, Ara C, Conti Dvirgiliis, L. The effect of retinoic acid on the re-establishment of differentiated hepatocyte phenotype in primary culture. Cell Tissue Res 1998; 293: 337-47.
18. Zauli G, Visani G, Bassini A, Caramelli E, Ottaviani E, Bertolaso L, Bertagnolo, V, Borgatti P, Capitani S. Nuclear translocation of protein kinase C-α and -ζ isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid. Br J Haematol 1996; 93: 542-50.
19. Bertagnolo, V, Marchisio, M, Capitani, S, Neri LM. Intranuclear translocation of phospholipase C-β2 during HL-60 myeloid differentiation. Biochem Biophys Res Commun 1997; 235: 831-7.
20. Bertagnolo V, Neri LM, Marchisio M, Mischiati C, Capitani S. Phosphoinositide 3-kinase activity is essential for ATRA-induced granulocytic differentiation of HL-60 cells. Cancer Res 1999; 59: 542-6.
21. Morsiani E, Rozga, J, Scott HC, Lebow LT, Moscioni AD, Kong LB, McGrath MF and Demetriou AA. Automated liver cell processing facilitates large scale isolation and purification of porcine hepatocytes. ASAIO J 1995; 41: 155-61.
22. Colamussi ML, Secchiero P, Gonelli A, Marchisio M, Zauli G, Capitani S. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional upregulation of the Fas (CD95)/Fas ligand (CD95L) pathway. J Leukoc Biol 2001; 69: 263-70.
23. Mets B, Hickman R. Allin R, Van Dyk J, Lotz Z. Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver. Hepatology 1993; 17: 668-76.
24. Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. J Biol Chem 1996; 271: 11484-92.
25. Albrecht JH, Hansen LK. Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ 1999; 10: 397-404.
26. Gezer S, Yasin Z, Imren S, Freeman J, Black A, Raza A. Changes observed in the growth fraction, labeling index, duration of S phase, and total cell cycle times of HL-60 cell as they undergo differentiation in response to retinoic acid. Cancer Res 1988; 48: 5989-94.
27. Leclercq I, Saliez A, Wallemacq PE, Horsmans Y, Lambotte L. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemia liver injury in the rat. Hepatology 1997; 26: 1182-8.
28. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000; 279: L429-38.
29. Radominska-Pandya A, Chen G, Czernik PJ, Little JM, Samokyszyn VM, Carter CA, Nowak G. Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). J Biol Chem 2000; 275: 22324-30.
30. Bertagnolo V, Marchisio M, Volinia S, Caramelli E, Capitani S. Nuclear association of tyrosine-phosphorylated Vav to phospholipase C-gamma1 and phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells. FEBS Lett 1998; 441: 480-4.
31. Payrastre B, Missy, Giuriato S, Bodin S, Plantavid M, Gratacap M. Phosphoinositides: Key players in cell signalling, in time and space. Cell Signal 2001; 13: 377-87.
32. Nojiri S, Hock JB. Suppression of epidermal growth factor-induced phospholipase C activation associated with actin rearrangement in rat hepatocytes in primary culture. Hepatology 2000; 32: 947-57.
33. Dajani OF, Sandnes D, Melien O, Rezvani F, Nilssen LS, Thoresen GH, Christoffer T. Role of diacilglycerol (DAG) in hormonal induction of S phase in hepatocytes: The DAG-dependent protein kinase C pathway is not activated by epidermal growth factor (EGF), but is involved in mediating the enhancement of responsiveness to EGF by vasopressin, angiotensin II, and norepinephrine. J Cell Physiol 1999; 180: 203-14.